Fc-effector functions for selecting COVID-19 convalescent plasma

In a recent study posted to the bioRxiv* preprint server, researchers demonstrated that coronavirus disease 2019 (COVID-19) convalescent plasmas (CCPs) with low neutralizing and high fragment crystallizable (Fc)-effector activity result in effective prophylaxis.

Related Keywords

,Elkhophoto Shutterstock ,Convalescent Plasma ,Coronavirus Disease Covid 19 ,Dcc ,Antibodies ,Ntibody ,Bioluminescence ,Bioluminescence Imaging ,Rain ,Coronavirus ,Cytotoxicity ,Efficacy ,Maging ,Mmunoglobulin ,N Vivo ,Inflammation ,Lungs ,Acrophage ,Ortality ,Eutrophils ,Phagocytosis ,Prophylaxis ,Protein ,Espiratory ,Cars ,Ars Cov 2 ,Evere Acute Respiratory ,Evere Acute Respiratory Syndrome ,Yndrome ,Weight Loss ,